Literature DB >> 1249180

Catecholamines metabolism in thyroid diseases. I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism.

P Coulombe, J H Dussault, J Letarte, S J Simmard.   

Abstract

We have measured the secretion rate of epinephrine in 6 euthyroid, 6 hyperthyroid, and 6 hypothyroid subjects infused at a constant rate for a one hour period with tritiated epinephrine (.01 muc/kg/min) (New England Nuclear Inc.). Plasma and urinary levels of epinephrine were measured by modifying the fluorometric method of Anton and Sayre. Plasma levels of epinephrine were 3.0 +/- 3.0 ng/100 ml (mean +/- SD) in normal subjects, compared to 4.4 +/- 3.5 ng/100 ml (mean +/- SD) in hyperthyroid subjects. In urine, epinephrine values ranged from 1.3 mug/day to 6.1 mug/day in normal subjects. Mean value observed in hyperthyroidism was 4.9 +/- 2.6 mug/day and 3.8 +/- 1.0 mu/day in hypothyroidism. Plasma secretion rates averaged 48 +/- 27 mug/kg/day in normal subjects, compared to 54 +/- 18 mu/kg/day in hyperthyroidism and 43 +/- 20 mug/kg/day in hypothyroidism. Likewise, the mean urinary secretion rate was 55 +/- 27 mug/kg/day in normal subjects compared to 60 +/- 22 mug/kg/day in hyperthyroidism and 50 +/- 28 mug/kg/day in hypothyroidism. There is no statistical difference between the values found in the three groups of subjects (plasma and urine). Therefore, these results would indicate that the signs and symptoms encountered in hyperthyroidism are not secondary to a high secretion rate of epinephrine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249180     DOI: 10.1210/jcem-42-1-125

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Thyroid emergencies.

Authors:  Nicholas J Sarlis; Loukas Gourgiotis
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

3.  Functional state of the autonomic nervous system in patients with euthyroid and thyrotoxic goiter.

Authors:  V N Aleksandrov; S Z Kletskin; I A Shukhgalter; I V Akatov; T I Nikitina; B I Gorbatyi
Journal:  Neurosci Behav Physiol       Date:  1986 Nov-Dec

Review 4.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

5.  Coma secondary to apathetic thyrotoxicosis.

Authors:  O Serri; R M Gagnon; Y Goulet; M Somma
Journal:  Can Med Assoc J       Date:  1978-09-23       Impact factor: 8.262

6.  Influence of hypo- and hyperthyroidism on plasma catecholamines in pithed rats.

Authors:  M Nagel-Hiemke; G Gross; I Lues; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

7.  Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Studies on metabolic alterations after a mixed meal and during a 39-hour fast in thyrotoxicosis.

Authors:  G Federspil; M Zaccaria; N Sicolo; C De Palo; E Zago; A Boninsegna; M Bevilacqua; C Scandellari
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

9.  Interrelationships among thyroxine, growth hormone, and the sympathetic nervous system in the regulation of 5'-iodothyronine deiodinase in rat brown adipose tissue.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Effect of thyroid status on beta-adrenoceptors and calcium channels in rat cardiac and vascular tissue.

Authors:  M H Hawthorn; P Gengo; X Y Wei; A Rutledge; J F Moran; S Gallant; D J Triggle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.